#Japan #Minato #SIMPRESEARCH #4DIN #Yugo Goto

4DIN Appoints Yugo Goto as Chief Strategy Officer

In a significant move to advance drug development, 4DIN, headquartered in Minato, Tokyo, has announced the appointment of Yugo Goto as the Chief Strategy Officer (CSO), effective August 2026. This strategic leadership transition is set to accelerate the integration of clinical data from university hospitals into drug research and development processes, thus addressing critical challenges faced by pharmaceutical companies.

4DIN has established a strong presence in the healthcare data analytics sector, providing its clinical information analysis support platform, SIMPRESEARCH®, to 26 out of 81 university hospitals across Japan. This platform has become instrumental in leveraging medical data effectively. Additionally, the launch of the Real World Insight™ service, which accesses statistical data from electronic medical records of university hospitals, aims to facilitate feasibility studies for research and development, thus expanding the practical applications of accumulated medical data in various clinical settings.

Through Goto's leadership, 4DIN aims to create solutions that align the challenges faced in pharmaceutical environments with the robust data resources available in university hospitals. The focus will be on integrating real-world data usage among healthcare providers, researchers, and life sciences companies to foster a collaborative ecosystem that enhances the overall medical research landscape.

Advancing the 4DIN Research Network

The 4DIN Research Network will witness significant advancements under Goto’s guidance, utilizing his extensive clinical development experience in the pharmaceutical industry, coupled with his insights from cross-industry collaboration. The aim is to connect university hospitals, researchers, and life sciences firms more effectively, thereby enhancing the overall operational processes for clinical trials and the efficacy of research and development efforts.

Key Initiatives:

1. Streamlined Case Registration: Utilizing clinical information from university hospitals to better identify potential patient groups and assist with pre-screening tasks.
2. Decision Support for R&D: Leveraging statistical insights derived from hospital data to assist in understanding patient demographics and actual clinical practices.
3. Promotion of Industry-Academia Collaboration: Closing the gap between the challenges faced by life sciences firms and the data held by university hospitals, thereby broadening co-creation opportunities.
4. Advanced Data Utilization Through AI: Aggregating diverse information necessary for research and development in a secure environment where stakeholders can utilize it reliably, with an emphasis on practical AI implementation for informed decision-making.

About Yugo Goto

Yugo Goto holds a master's degree from Shizuoka Prefectural University, with a focus on pharmacy. His career in the pharmaceutical industry began in 2008, where he was involved in drug development within the psychiatric and neurological domains. Following this, he joined a foreign pharmaceutical company in 2014, where he spearheaded development strategies and clinical project management in the immunology and oncology sectors, contributing to the market launch of multiple products. Most recently, he served as the Clinical Development Planning Department head since 2024, actively engaging in the digital transformation of drug development through RWD and AI initiatives.

Goto's public speaking engagements are notable, including the upcoming Ubie Pharma Summit 2026 and various webinars aimed at enhancing the usage of RWD in decision-making processes. His expertise and vision are anticipated to drive 4DIN towards becoming a hub for healthcare data accessibility and utilization.

About 4DIN, Inc.

4DIN’s mission is to visualize life science data to benefit patients, ensuring that all stakeholders – from healthcare institutions to researchers and companies – can utilize data effectively in generating new value. Founded in June 2003 by Takahashi Seihiko, the company has made considerable strides in developing, selling, and maintaining medical information analysis platforms, contributing significantly to healthcare innovation in Japan.

Corporate Information:

• - Location: 2-20-15 Shimbashi, Minato, Tokyo, 105-0004, Japan
• - Website: 4din.com